These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16920808

  • 1. Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction.
    Onai Y, Suzuki J, Maejima Y, Haraguchi G, Muto S, Itai A, Isobe M.
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H530-8. PubMed ID: 16920808
    [Abstract] [Full Text] [Related]

  • 2. Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.
    Gu Y, Wang X, Wang X, Yuan M, Wu G, Hu J, Tang Y, Huang C.
    Tohoku J Exp Med; 2012 Jul; 227(3):161-70. PubMed ID: 22729178
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
    Buss SJ, Muenz S, Riffel JH, Malekar P, Hagenmueller M, Weiss CS, Bea F, Bekeredjian R, Schinke-Braun M, Izumo S, Katus HA, Hardt SE.
    J Am Coll Cardiol; 2009 Dec 15; 54(25):2435-46. PubMed ID: 20082935
    [Abstract] [Full Text] [Related]

  • 4. A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration.
    Wakatsuki S, Suzuki J, Ogawa M, Masumura M, Muto S, Shimizu T, Takayama K, Itai A, Isobe M.
    Expert Opin Ther Targets; 2008 Dec 15; 12(12):1469-76. PubMed ID: 19007316
    [Abstract] [Full Text] [Related]

  • 5. Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model.
    Zhang H, Zhong H, Everett TH, Wilson E, Chang R, Zeng D, Belardinelli L, Olgin JE.
    Heart Rhythm; 2014 Jan 15; 11(1):101-9. PubMed ID: 24120874
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats.
    Pan Y, Zhu W, Ma J, Xin P, Han B, He Y, Wang Y, Peng T, Wei M.
    Arch Cardiovasc Dis; 2011 Jan 19; 104(1):17-28. PubMed ID: 21276574
    [Abstract] [Full Text] [Related]

  • 11. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A, Lu Y, Zheng Q, Zhang J, Zhao Y, Zhao M, Cui X.
    Cell Physiol Biochem; 2018 Jan 19; 45(5):1797-1806. PubMed ID: 29510381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT.
    J Cardiovasc Pharmacol; 2015 Mar 19; 65(3):269-75. PubMed ID: 25658462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic therapy with nipradilol, a beta-adrenergic blocker, attenuated left ventricular remodeling following myocardial infarction in rats.
    Sonoki H, Nakamura M, Takeshita A.
    Jpn J Pharmacol; 1997 Jun 19; 74(2):171-8. PubMed ID: 9243325
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 19; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A.
    Circulation; 2003 Oct 28; 108(17):2134-40. PubMed ID: 14517168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.